SCHEDULE: Vanguard Group Discloses 11.27% Passive Stake in Becton Dickinson & Co

The Vanguard Group has filed an amended Schedule 13G, reporting a passive beneficial ownership of 11.27% in Becton Dickinson & Co's common stock as of June 30, 2025.

Summary

• The Vanguard Group, based in Malvern, PA, has filed an Amendment No. 12 to Schedule 13G regarding its beneficial ownership in Becton Dickinson & Co.
• As of June 30, 2025, Vanguard beneficially owns an aggregate of 32,308,728 shares of Becton Dickinson & Co's Common Stock.
• This ownership represents 11.27% of the class of securities.
• Vanguard holds sole voting power over 0 shares, shared voting power over 361,620 shares, sole dispositive power over 30,930,700 shares, and shared dispositive power over 1,378,028 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Becton Dickinson & Co.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a 13G is a factual ownership report, a large, passive stake by a reputable firm like Vanguard can be seen as a positive indicator of long-term stability and inclusion in major indices, without implying any immediate operational or financial changes.

Positives

• The filing indicates a significant, stable institutional investment by The Vanguard Group, a major passive asset manager, which can be viewed as a vote of confidence in Becton Dickinson & Co's long-term prospects.
• The passive nature of the investment, as certified by Vanguard, suggests no immediate intent to influence or change the control of the issuer, providing stability.

Negatives

• No specific negative information is contained within this beneficial ownership report.

Risks

• No specific risks related to Becton Dickinson & Co's operations or financial health are disclosed in this beneficial ownership filing, as it pertains solely to The Vanguard Group's stake.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Becton Dickinson & Co's future performance or outlook.

Industry Context

This filing reflects a routine disclosure by a major passive investment firm, The Vanguard Group, regarding its significant stake in a leading medical technology company, Becton Dickinson & Co. Such large, passive holdings are common for index funds and broad market ETFs managed by firms like Vanguard, indicating Becton Dickinson's inclusion in major market indices.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming a large, passive investment by The Vanguard Group. This can reassure investors about the company's inclusion in major indices and long-term institutional interest.
• Management: Confirms that a major shareholder holds its stake passively, without intent to influence control, which may allow management to focus on long-term strategic objectives without immediate activist pressure.

Key Dates

Keywords

Becton Dickinson & Co, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, Medical Technology, Healthcare